| Kristen Marie Browski, OD | |
|
735 John R Rd Ste 150, Troy, MI 48083-5859 | |
| (248) 577-3659 | |
| (248) 588-9917 |
| Full Name | Kristen Marie Browski |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 14 Years |
| Location | 735 John R Rd Ste 150, Troy, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568770782 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4901004596 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| P-cor Llc | 9931194149 | 77 |
News Archive
The UK soft drinks industry levy, due to be introduced in April 2018, is estimated to have significant health benefits, especially among children, according to the first study to estimate its health impact, published in The Lancet Public Health.
A study published in the Journal of Clinical Endocrinology & Metabolism is the first report of an oral probiotic supplement significantly increasing circulating vitamin D levels in the blood.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues.
› Verified 8 days ago
| Provider Name | P-cor Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1720033343 PECOS PAC ID: 9931194149 Enrollment ID: O20040417000048 |
News Archive
The UK soft drinks industry levy, due to be introduced in April 2018, is estimated to have significant health benefits, especially among children, according to the first study to estimate its health impact, published in The Lancet Public Health.
A study published in the Journal of Clinical Endocrinology & Metabolism is the first report of an oral probiotic supplement significantly increasing circulating vitamin D levels in the blood.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristen Marie Browski, OD 5500 Auto Club Dr, Roseville, Dearborn, MI 48126-2779 Ph: (313) 562-8000 | Kristen Marie Browski, OD 735 John R Rd Ste 150, Troy, MI 48083-5859 Ph: (248) 577-3659 |
News Archive
The UK soft drinks industry levy, due to be introduced in April 2018, is estimated to have significant health benefits, especially among children, according to the first study to estimate its health impact, published in The Lancet Public Health.
A study published in the Journal of Clinical Endocrinology & Metabolism is the first report of an oral probiotic supplement significantly increasing circulating vitamin D levels in the blood.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues.
› Verified 8 days ago
Sandra Shina Hou, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2001 W Maple Rd, Wal Mart Vision Center, Troy, MI 48084 Phone: 248-435-4126 Fax: 248-435-4162 | |
Svs Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6828 Rochester Rd, Troy, MI 48085 Phone: 248-710-1100 Fax: 248-786-2928 | |
Andrea M. Langolf, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2877 Crooks Rd, Ste B, Troy, MI 48084 Phone: 248-822-7003 Fax: 248-822-7008 | |
Sasha Shammami Kashat, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1301 Coolidge Hwy, Troy, MI 48084 Phone: 248-643-9880 | |
Dr. Rhonda Elisha Thompson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 735 John R Rd, Troy, MI 48083 Phone: 248-951-0000 Fax: 248-528-4040 | |
Dr. Bruce Richard Wolffis, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 735 John R Rd Ste 150, Troy, MI 48083 Phone: 248-577-3659 Fax: 248-588-9917 | |
Dr. Timothy Schrot, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 506 W 14 Mile Rd, Troy, MI 48083 Phone: 248-589-8240 Fax: 248-589-2597 |